Upgrade to SI Premium - Free Trial

LKFT (LKFT)

27.90 -0.02 (0.07%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/12/26)

Latest Headlines

Form 6-K Lakefront Biotherapeutic For: Sep 15 September 15, 2026 4:28 PM - SEC Filing Form 6-K Lakefront Biotherapeutic For: Aug 25 August 25, 2026 4:31 PM - SEC Filing Form 6-K Lakefront Biotherapeutic For: Aug 25 August 25, 2026 10:29 AM - SEC Filing Form 6-K Lakefront Biotherapeutic For: Aug 25 August 25, 2026 10:26 AM - SEC Filing TD Cowen Starts Lakefront Biotherapeutics (LKFT) at Buy August 21, 2026 5:12 AM - StreetInsider Keymed Biosciences Announces 2026 H1 Results and Business Updates August 20, 2026 10:10 AM - PR NewsWire Form 6-K Lakefront Biotherapeutic For: Aug 18 August 18, 2026 4:38 PM - SEC Filing Form 6-K Lakefront Biotherapeutic For: Aug 12 August 12, 2026 4:45 PM - SEC Filing Form 6-K Lakefront Biotherapeutic For: Aug 12 August 12, 2026 7:59 AM - SEC Filing Lakefront Biotherapeutics (LKFT) PT Lowered to $26 at Morgan Stanley August 11, 2026 9:09 AM - StreetInsider Lakefront Biotherapeutics (LKFT) PT Lowered to $26 at RBC Capital August 11, 2026 7:58 AM - StreetInsider Paulo Fontoura resigns from Lakefront Biotherapeutics board July 13, 2026 4:01 PM - StreetInsider Lakefront Announces Paulo Fontoura has Resigned from its Board following his Appointment as Global Head of R&D at Sanofi July 13, 2026 4:01 PM - Globe NewsWire Morgan Stanley Resumes Lakefront Biotherapeutics (LKFT) at Equalweight July 10, 2026 2:40 AM - StreetInsider Full Article List